N. Galie, M. Hoeper, M. Humbert, A. Torbicki, J. Vachiery et al., Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of: Guidelines for the diagnosis and treatment of pulmonary hypertension, Cardiology International Society of Heart and Lung Transplantation (ISHLT) Eur Respir J, vol.34, pp.1219-1263, 2009.

G. Simonneau, I. Robbins, M. Beghetti, R. Channick, M. Delcroix et al., Updated Clinical Classification of Pulmonary Hypertension, Journal of the American College of Cardiology, vol.54, issue.1, pp.43-54, 2009.
DOI : 10.1016/j.jacc.2009.04.012

M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib et al., Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006.
DOI : 10.1164/rccm.200510-1668OC

B. Sztrymf, A. Yaici, and H. M. Girerd, Genes and Pulmonary Arterial Hypertension, Respiration, vol.74, issue.2, pp.123-155, 2007.
DOI : 10.1159/000098818

B. Sztrymf, F. Coulet, B. Girerd, A. Yaici, X. Jais et al., Mutation, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.12, pp.1377-83, 2008.
DOI : 10.1164/rccm.200712-1807OC
URL : https://hal.archives-ouvertes.fr/inserm-00668454

E. Stacher, B. Graham, J. Hunt, A. Gandjeva, D. Groshong et al., Modern Age Pathology of Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.186, issue.3, pp.261-72, 2012.
DOI : 10.1164/rccm.201201-0164OC

C. Rubens, R. Ewert, M. Halank, R. Wensel, H. Orzechowski et al., Big Endothelin-1 and Endothelin-1 Plasma Levels Are Correlated With the Severity of Primary Pulmonary Hypertension, Chest, vol.120, issue.5, pp.1562-1571, 2001.
DOI : 10.1378/chest.120.5.1562

A. Giaid, M. Yanagisawa, D. Langleben, R. Michel, R. Levy et al., Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension, New England Journal of Medicine, vol.328, issue.24, pp.1732-1741, 1993.
DOI : 10.1056/NEJM199306173282402

M. Laughlin, V. , M. Goon, and M. , Pulmonary Arterial Hypertension, Circulation, vol.114, issue.13, pp.1417-1448, 2006.
DOI : 10.1161/CIRCULATIONAHA.104.503540

B. Christman, C. Mcpherson, J. Newman, G. King, G. Bernard et al., An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary Hypertension, New England Journal of Medicine, vol.327, issue.2, pp.70-75, 1992.
DOI : 10.1056/NEJM199207093270202

R. Tuder, C. Cool, M. Geraci, J. Wang, S. Abman et al., Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.159, issue.6, pp.1925-1957, 1999.
DOI : 10.1164/ajrccm.159.6.9804054

M. Mc-lean, P. Herve, S. Eddahibi, and S. Adnot, 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension, British Journal of Pharmacology, vol.98, issue.Suppl., pp.161-169, 2000.
DOI : 10.1038/sj.bjp.0703570

Y. Liu, H. Tian, X. Yan, F. Fan, W. Wang et al., Serotonin inhibits apoptosis of pulmonary artery smooth muscle cell by pERK1/2 and PDK through 5-HT1B receptors and 5-HT transporters. Cardiovascular Pathol Epub ahead of print, 2013.

L. Abenhaim, Y. Moride, F. Brenot, S. Rich, J. Benichou et al., Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension, New England Journal of Medicine, vol.335, issue.9, pp.609-625, 1996.
DOI : 10.1056/NEJM199608293350901

R. Tuder, M. Chacon, L. Alger, J. Wang, L. Taraseviciene-stewart et al., Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis, The Journal of Pathology, vol.88, issue.3, pp.367-74, 2001.
DOI : 10.1002/path.953

R. Schermuly, E. Dony, H. Ghofrani, S. Pullamsetti, R. Savai et al., Reversal of experimental pulmonary hypertension by PDGF inhibition, Journal of Clinical Investigation, vol.115, issue.10, pp.2811-2832, 2005.
DOI : 10.1172/JCI24838

J. Yuan, A. Aldinger, M. Juhaszova, J. Wang, J. Conte et al., Dysfunctional Voltage-Gated K+ Channels in Pulmonary Artery Smooth Muscle Cells of Patients With Primary Pulmonary Hypertension, Circulation, vol.98, issue.14, pp.1400-1406, 1998.
DOI : 10.1161/01.CIR.98.14.1400

S. Duong-quy, S. Riviere, D. Ngo, C. Le-dong, N. Hua-huy et al., Hypertension pulmonaire??: de la physiopathologie mol??culaire aux anomalies h??modynamiques, Revue des Maladies Respiratoires, vol.29, issue.8, pp.956-70, 2012.
DOI : 10.1016/j.rmr.2012.03.009

R. Barst, L. Chung, R. Zamanian, M. Turner, and M. Mcgoon, Functional Class Improvement and Three-Year Survival Outcomes in Patients With Pulmonary Arterial Hypertension in the REVEAL Registry

D. Mereles, N. Ehlken, S. Kreuscher, S. Ghofrani, M. Hoeper et al., Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension, Circulation, vol.114, issue.14, pp.1482-1489, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.618397

M. Humbert, O. Sitbon, and G. Simonneau, Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1461, 2004.
DOI : 10.1056/NEJMra040291
URL : https://hal.archives-ouvertes.fr/hal-01455600

R. Barst, L. Rubin, W. Long, M. Mcgoon, S. Rich et al., Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension, N Engl J Med, vol.34, pp.296-301, 1996.

M. Hoeper, M. Schwarze, S. Ehlerding, A. Adler-schuermeyer, E. Spiekerkoetter et al., Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue, New England Journal of Medicine, vol.342, issue.25, pp.1866-70, 2000.
DOI : 10.1056/NEJM200006223422503

G. Simonneau, R. Barst, N. Galie, R. Naeje, S. Rich et al., Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.165, issue.6, pp.800-804, 2002.
DOI : 10.1164/ajrccm.165.6.2106079

V. Mclaughlin, O. Sitbon, D. Badesch, R. Barst, C. Black et al., Survival with first-line bosentan in patients with primary pulmonary hypertension, European Respiratory Journal, vol.25, issue.2, pp.244-253, 2005.
DOI : 10.1183/09031936.05.00054804

N. Galiè, H. Olschewski, R. Oudiz, F. Torres, A. Frost et al., Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2, Efficacy Studies (ARIES) Group, pp.3010-3019, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.742510

N. Galie, H. Ghofrani, A. Torbicki, R. Barst, L. Rubin et al., Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.353, issue.20, pp.2148-57, 2005.
DOI : 10.1056/NEJMoa050010

N. Galiè, B. Brundage, H. Ghofrani, R. Oudiz, G. Simonneau et al., Tadalafil Therapy for Pulmonary Arterial Hypertension, Circulation, vol.119, issue.22, pp.2894-903, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.839274

J. Sandoval, J. Gaspar, H. Peña, L. Santos, J. Córdova et al., Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension, European Respiratory Journal, vol.38, issue.6, pp.1343-1351, 2011.
DOI : 10.1183/09031936.00072210

P. Dartevelle, E. Fadel, S. Mussot, A. Chapelier, P. Hervé et al., Chronic thromboembolic pulmonary hypertension, European Respiratory Journal, vol.23, issue.4, pp.637-685, 2004.
DOI : 10.1183/09031936.04.00079704

M. Hoeper and J. Granton, Intensive Care Unit Management of Patients with Severe Pulmonary Hypertension and Right Heart Failure, American Journal of Respiratory and Critical Care Medicine, vol.184, issue.10, pp.1114-1138, 2011.
DOI : 10.1164/rccm.201104-0662CI

J. Lordan and P. Corris, Pulmonary arterial hypertension and lung transplantation, Expert Review of Respiratory Medicine, vol.5, issue.3, pp.441-54, 2011.
DOI : 10.1586/ers.11.21

A. Tonelli, V. Arelli, O. Minai, J. Newman, N. Bair et al., Causes and Circumstances of Death in Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.188, issue.3, 2013.
DOI : 10.1164/rccm.201209-1640OC

F. Haddad, S. Hunt, D. Rosenthal, and D. Murphy, Right Ventricular Function in Cardiovascular Disease, Part I: Anatomy, Physiology, Aging, and Functional Assessment of the Right Ventricle, Circulation, vol.117, issue.11, pp.1438-1486, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.653576

H. Bogaard, K. Abe, V. Noordegraaf, A. Voelkel, and N. , The Right Ventricle Under Pressure, Chest, vol.135, issue.3, pp.794-804, 2009.
DOI : 10.1378/chest.08-0492

J. Bishop, S. Rhodes, and G. Laurent, Increased collagen synthesis and decreased collagen degradation in right ventricular hypertrophy induced by pressure overload, Cardiovascular Research, vol.28, issue.10, pp.1581-1585, 1994.
DOI : 10.1093/cvr/28.10.1581

T. Herron and K. Mcdonald, Small Amounts of alpha-Myosin Heavy Chain Isoform Expression Significantly Increase Power Output of Rat Cardiac Myocyte Fragments, Circulation Research, vol.90, issue.11, pp.1150-1152, 2002.
DOI : 10.1161/01.RES.0000022879.57270.11

F. De-man, M. Handoko, C. Guignabert, and H. Bogaard, Neurohormonal Axis in Patients with Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.1, pp.14-19, 2013.
DOI : 10.1164/rccm.201209-1663PP

F. Giordano, Oxygen, oxidative stress, hypoxia, and heart failure, Journal of Clinical Investigation, vol.115, issue.3, pp.500-508, 2005.
DOI : 10.1172/JCI200524408

L. Pia, G. Marsboom, and S. Archer, Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure, Journal of Molecular Medicine, vol.298, issue.Suppl 1, pp.1011-1031, 2010.
DOI : 10.1007/s00109-010-0679-1

F. Haddad, R. Doyle, D. Murphy, and S. Hunt, Right Ventricular Function in Cardiovascular Disease, Part II: Pathophysiology, Clinical Importance, and Management of Right Ventricular Failure, Circulation, vol.117, issue.13, pp.1717-1748, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.653584

M. Kurzyna, J. Zy?kowska, A. Fija?kowska, M. Florczyk, M. Wieteska et al., Characteristics and prognosis of patients with decompensated right ventricular failure during the course of pulmonary hypertension, Kardiol Pol, vol.66, issue.10, pp.1033-1039, 2008.

T. Huynh, S. Weigt, C. Sugar, S. Shapiro, and E. Kleerup, Prognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit, Journal of Critical Care, vol.27, issue.6, pp.739-746, 2012.
DOI : 10.1016/j.jcrc.2012.08.006

B. Sztrymf, L. Bertoletti, R. Souza, A. Hamid, X. Jaïs et al., Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension, European Respiratory Journal, vol.35, issue.6, pp.1286-93, 2010.
DOI : 10.1183/09031936.00070209

K. Olsson, N. Nickel, J. Tongers, and M. Hoeper, Atrial flutter and fibrillation in patients with pulmonary hypertension, International Journal of Cardiology, vol.167, issue.5, pp.2300-2305, 2013.
DOI : 10.1016/j.ijcard.2012.06.024

A. Mercat, J. Diehl, and G. Meyer, Hemodynamic effects of fluid loading in acute massive pulmonary embolism, Critical Care Medicine, vol.27, issue.3, pp.540-544, 1999.
DOI : 10.1097/00003246-199903000-00032

Y. Ozier, O. Dubourg, and J. Fargot, Circulatory failure in acute pulmonary embolism, Intensive Care Medicine, vol.76, issue.2, pp.91-97, 1984.
DOI : 10.1007/BF00297565

D. Alonzo, G. Barst, R. Ayres, S. Bergofsky, E. Brundage et al., Survival in Patients with Primary Pulmonary Hypertension, Annals of Internal Medicine, vol.115, issue.5, pp.343-352, 1991.
DOI : 10.7326/0003-4819-115-5-343

R. Benza, D. Miller, M. Gomberg-maitland, R. Frantz, A. Foreman et al., Predicting Survival in Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL), Circulation, vol.122, issue.2, pp.164-72, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.898122

M. Hoeper, S. Lee, R. Voswinckel, M. Palazzini, X. Jais et al., Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced Centers, Journal of the American College of Cardiology, vol.48, issue.12, pp.2546-52, 2006.
DOI : 10.1016/j.jacc.2006.07.061

S. Brimioulle, P. Wauthy, P. Ewalenko, B. Rondelet, F. Vermeulen et al., Single-beat estimation of right ventricular end-systolic pressure-volume relationship, American Journal of Physiology - Heart and Circulatory Physiology, vol.284, issue.5, pp.1625-1655, 2003.
DOI : 10.1152/ajpheart.01023.2002

F. Kerbaul, B. Rondelet, S. Motte, P. Fesler, I. Hubloue et al., Effects of norepinephrine and dobutamine on pressure load-induced right ventricular failure*, Critical Care Medicine, vol.32, issue.4, pp.1035-1075, 2004.
DOI : 10.1097/01.CCM.0000120052.77953.07

F. Kerbaul, P. Rondelet, J. Demester, P. Fesler, S. Huez et al., Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure*, Critical Care Medicine, vol.34, issue.11, pp.2814-2823, 2006.
DOI : 10.1097/01.CCM.0000242157.19347.50

M. Revermann, M. Schloss, A. Mieth, A. Babelova, K. Schröder et al., Levosimendan attenuates pulmonary vascular remodeling, Intensive Care Medicine, vol.96, issue.8, pp.1368-77, 2011.
DOI : 10.1007/s00134-011-2254-9

L. Price, P. Forrest, V. Sodhi, D. Adamson, C. Nelson-piercy et al., Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension, British Journal of Anaesthesia, vol.99, issue.4, pp.552-557, 2007.
DOI : 10.1093/bja/aem180

E. Braun, C. Palin, and C. Hogue, Vasopressin During Spinal Anesthesia in a Patient with Primary Pulmonary Hypertension Treated with Intravenous Epoprostenol, Anesthesia & Analgesia, vol.99, issue.1, pp.36-43, 2004.
DOI : 10.1213/01.ANE.0000121349.15880.DC

P. Reilly, K. Wilkins, K. Fuh, U. Haghlund, and G. Bulkley, THE MESENTERIC HEMODYNAMIC RESPONSE TO CIRCULATORY SHOCK: AN OVERVIEW, Shock, vol.15, issue.5, pp.329-372, 2001.
DOI : 10.1097/00024382-200115050-00001

A. Mebazaa, P. Karpati, E. Renaud, and L. Algotsson, Acute right ventricular failure???from pathophysiology to new treatments, Intensive Care Medicine, vol.100, issue.2, pp.185-96, 2004.
DOI : 10.1007/s00134-003-2025-3

A. Campo, S. Mathai, L. Pavec, J. Zaiman, A. Hummers et al., Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension, European Respiratory Journal, vol.38, issue.2, pp.359-67, 2011.
DOI : 10.1183/09031936.00148310

F. Haddad, T. Peterson, E. Fuh, K. Kudelko, J. De et al., Characteristics and Outcome After Hospitalization for Acute Right Heart Failure in Patients With Pulmonary Arterial Hypertension, Circulation: Heart Failure, vol.4, issue.6, pp.692-701, 2011.
DOI : 10.1161/CIRCHEARTFAILURE.110.949933

N. Galie and L. Rubin, Introduction: new insights into a challenging disease, Journal of the American College of Cardiology, vol.43, issue.12, pp.1-90, 2004.
DOI : 10.1016/j.jacc.2004.03.003

B. Sztrymf and H. M. , Practical management of pulmonary arterial hypertension in the intensive care unit, Pulmonary hypertension. Informa Heathcare USA, pp.455-61, 2009.

J. Watts, M. Marchick, and J. Kline, Right Ventricular Heart Failure From Pulmonary Embolism: Key Distinctions From Chronic Pulmonary Hypertension, Journal of Cardiac Failure, vol.16, issue.3, pp.250-259, 2010.
DOI : 10.1016/j.cardfail.2009.11.008

R. Kelly, C. Hayward, A. Avolio, O. Rourke, and M. , Noninvasive determination of age-related changes in the human arterial pulse, Circulation, vol.80, issue.6, pp.1652-1661, 1989.
DOI : 10.1161/01.CIR.80.6.1652

R. Kelly, H. Gibbs, O. Rourke, M. Daley, J. Mang et al., Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery, European Heart Journal, vol.11, issue.2, pp.138-182, 1990.
DOI : 10.1093/oxfordjournals.eurheartj.a059669

H. Miyashita, Clinical Assessment of Central Blood Pressure, Current Hypertension Reviews, vol.8, issue.2, pp.80-90, 2012.
DOI : 10.2174/157340212800840708

D. Chemla and B. Lamia, Monitorage h??modynamique non-invasif en r??animation??: int??r??t potentiel de la tonom??trie art??rielle, R??animation, vol.18, issue.3, pp.197-200, 2009.
DOI : 10.1016/j.reaurg.2009.01.011

C. Chen, E. Nevo, B. Fetics, P. Pak, F. Yin et al., Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of Radial Tonometry Pressure : Validation of Generalized Transfer Function, Circulation, vol.95, issue.7, pp.1827-1863, 1997.
DOI : 10.1161/01.CIR.95.7.1827

S. Millasseau, S. Patel, S. Redwood, J. Ritter, and P. Chowienczyk, Pressure Wave Reflection Assessed From the Peripheral Pulse: Is a Transfer Function Necessary?, Hypertension, vol.41, issue.5, pp.1016-1036, 2003.
DOI : 10.1161/01.HYP.0000057574.64076.A5

O. Rourke, M. Adji, and A. , An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry, Curr Opin Cardiol, vol.20, pp.275-81, 2008.

S. Hope, I. Meredith, D. Tay, and J. Cameron, ???Generalizability??? of a radial-aortic transfer function for the derivation of central aortic waveform parameters, Journal of Hypertension, vol.25, issue.9, pp.1812-1832, 2007.
DOI : 10.1097/HJH.0b013e328277595d

B. Williams, P. Lacy, S. Thom, K. Cruickshank, A. Stanton et al., Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes, Circulation, vol.113, pp.1213-1225, 2006.

C. Vlachopoulos, K. Aznaouridis, O. Rourke, M. Safar, M. Baou et al., Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis, European Heart Journal, vol.31, issue.15, pp.1865-1871, 2010.
DOI : 10.1093/eurheartj/ehq024

G. Stevens, N. Fida, and J. Sanz, Computed tomography and cardiac magnetic resonnance imaging in pulmonary hypertension, Prog Cardiovasc Dis, vol.5, pp.161-71, 2012.

M. Van-de-veerdonk, T. Kind, and J. Marcus, Progressive Right Ventricular Dysfunction in Patients With Pulmonary Arterial Hypertension Responding to Therapy, Journal of the American College of Cardiology, vol.58, issue.24, pp.2511-2520, 2011.
DOI : 10.1016/j.jacc.2011.06.068

J. Marcus, C. Gan, and J. Zwanenburg, Interventricular Mechanical Asynchrony in Pulmonary Arterial Hypertension, Journal of the American College of Cardiology, vol.51, issue.7, pp.750-757, 2008.
DOI : 10.1016/j.jacc.2007.10.041

J. Cleland, J. Teerlink, and R. Senior, The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial, The Lancet, vol.378, issue.9792, pp.676-83, 2011.
DOI : 10.1016/S0140-6736(11)61126-4

J. Teerlink, C. Clarke, and K. Saikali, Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study, The Lancet, vol.378, issue.9792, pp.667-75, 2011.
DOI : 10.1016/S0140-6736(11)61219-1

C. Ronco, A. House, and M. Haapio, Cardiorenal syndrome: refining the definition of a??complex symbiosis gone wrong, Intensive Care Medicine, vol.66, issue.Suppl 3, pp.957-62, 2008.
DOI : 10.1007/s00134-008-1017-8

K. Damman, G. Navis, A. Voors, F. Asselbergs, T. Smilde et al., Worsening Renal Function and Prognosis in Heart Failure: Systematic Review and Meta-Analysis, Journal of Cardiac Failure, vol.13, issue.8, pp.599-608, 2007.
DOI : 10.1016/j.cardfail.2007.04.008

G. Smith, J. Lichtman, M. Bracken, M. Shlipak, C. Phillips et al., Renal Impairment and Outcomes in Heart Failure, Journal of the American College of Cardiology, vol.47, issue.10, 2006.
DOI : 10.1016/j.jacc.2005.11.084

G. Chertow, E. Burdick, M. Honour, J. Bonventre, and D. Bates, Acute Kidney Injury, Mortality, Length of Stay, and Costs in Hospitalized Patients, Journal of the American Society of Nephrology, vol.16, issue.11, pp.3365-70, 2005.
DOI : 10.1681/ASN.2004090740

G. Chertow, P. Palevsky, and T. Greene, Studying the Prevention of Acute Kidney Injury: Lessons from an 18th-Century Mathematician, Clinical Journal of the American Society of Nephrology, vol.1, issue.5, pp.1124-1131, 2006.
DOI : 10.2215/CJN.01200406

S. Gottlieb, W. Abraham, J. Butler, D. Forman, E. Loh et al., The prognostic importance of different definitions of worsening renal function in congestive heart failure, Journal of Cardiac Failure, vol.8, issue.3, pp.136-177, 2002.
DOI : 10.1054/jcaf.2002.125289

R. Schrier and W. Abraham, Hormones and hemodynamics in heart failure, N Engl J Med, vol.341, pp.577-585, 1999.

S. Shah, T. Thenappan, S. Rich, L. Tian, S. Archer et al., Association of Serum Creatinine With Abnormal Hemodynamics and Mortality in Pulmonary Arterial Hypertension, Circulation, vol.117, issue.19, pp.2475-83, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.719500

F. Haddad, E. Fuh, T. Peterson, M. Skhiri, K. Kudelko et al., Incidence, Correlates, and Consequences of Acute Kidney Injury in Patients With Pulmonary Arterial Hypertension Hospitalized With Acute Right-Side Heart Failure, Journal of Cardiac Failure, vol.17, issue.7, pp.533-542, 2011.
DOI : 10.1016/j.cardfail.2011.03.003

R. Schrier, Decreased Effective Blood Volume in Edematous Disorders: What Does This Mean?, Journal of the American Society of Nephrology, vol.18, issue.7, pp.2028-2031, 2007.
DOI : 10.1681/ASN.2006111302

R. Schrier and W. Wang, Acute Renal Failure and Sepsis, New England Journal of Medicine, vol.351, issue.2, pp.159-169, 2004.
DOI : 10.1056/NEJMra032401

P. Mccullough, Acute kidney injury with iodinated contrast, Critical Care Medicine, vol.36, issue.Suppl, pp.204-211, 2008.
DOI : 10.1097/CCM.0b013e318168cdc3

R. Zamanian, F. Haddad, R. Doyle, and A. Weinacker, Management strategies for patients with pulmonary hypertension in the intensive care unit*, Critical Care Medicine, vol.35, issue.9, pp.2037-50, 2007.
DOI : 10.1097/01.CCM.0000280433.74246.9E

T. Lahm, C. Mccaslin, T. Wozniak, W. Ghumman, Y. Fadl et al., Medical and Surgical Treatment of Acute Right Ventricular Failure, Journal of the American College of Cardiology, vol.56, issue.18, pp.1435-1481, 2010.
DOI : 10.1016/j.jacc.2010.05.046

M. Reade and D. Angus, PAC-Man: game over for the pulmonary artery catheter?, Critical Care, vol.10, issue.1, p.303, 2006.
DOI : 10.1186/cc3977